The Synovium in Rheumatoid Arthritis: Evidence for (at Least) Two Pathologies

Arthritis and Rheumatism

Volumn 50, Issue 1, 2004, Pages 1-4

  Kirwan, John R ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; GLUCOCORTICOID; PREDNISOLONE;

CLINICAL FEATURE; DISEASE SEVERITY; EDITORIAL; HUMAN; INCIDENCE; JOINT DESTRUCTION; JOINT RADIOGRAPHY; LOW DRUG DOSE; MACROPHAGE; MEDIATOR RELEASE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; RISK FACTOR; SYMPTOMATOLOGY; SYNOVIAL FLUID LEVEL; SYNOVITIS; SYNOVIUM;

ARTHRITIS, RHEUMATOID; HUMANS; SYNOVIAL MEMBRANE;

EID: 0345827529     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11496     Document Type: Editorial

References (25)

1. Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA. Progression of radiographic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 2004; 50:36-42.
2. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 years of rheumatoid arthritis: a prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
3. Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002;46:906-12.
4. Van Leeuwen, van der Heijde DM, Rijswijk MH, Houtman PM, van Riel PL, van de Puttte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis: a comparison of radiographic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:425-9.
5. Plant MJ, Saklatvala J, Borg AA, Jones PW, Dawes PT. Measurement and prediction of radiographical progression in early rheumatoid arthritis. J Rheumatol 1994;21:1808-13.
6. Kirwan JR. The relationship between synovitis and erosions in rheumatoid arthritis. Br J Rheumatol 1997;36:225-8.
7. Kirwan JR. Systemic low-dose glucocorticoid treatment in rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:389-403.
8. Pincus T, Ferraccioli G, Sokka T, Larsen A, Rau R, Kushner I, et al. Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review. Rheumatology (Oxford) 2002;41:1346-56.
9. Janossy G, Duke O, Poulter LW, Panayi G, Bofill M, Goldstein G. Rheumatoid arthritis: a disease of T lymphocyte/macrophage immunoregulation. Lancet 1981;2:839-42.
10. Gardner DL. Rheumatoid arthritis: cell and tissue pathology. In: Gardner DL, editor. Pathological basis of connective tissue diseases. London: Edward Arnold; 1992. p. 444-526.
11. Geiler T, Kriegsmann J, Keyszer GM, Gay RE, Gay S. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 1994;38:1664-71.
12. Pap T, Claus A, Ohtsu S, Hummel KM, Schwartz P, Drynda S, et al. Osteoclast-independent bone resorption by fibroblast-like cells. Arthritis Res 2003;5:R163-73.
13. Mulherin D, Fitzgerald O, Bresnihan B. Clinical improvement and radiographical deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996;35:1263-8.
14. Kirwan JR, Currey HL. Rheumatoid arthritis: disease modifying anti-rheumatic drugs. Clin Rheum Dis 1983;9:581-99.
15. Fell HD, Jubb RW. The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum 1977;20: 1359-72.
16. Kirwan JR, Byron M, Watt I. Relationship between soft tissue swelling, joint space narrowing and erosive damage in hand x-rays of patients with rheumatoid arthritis. Rheumatology 2001;40: 297-301.
17. Jevtic V, Rozman B, Watt I, Presetnik M. Use of contrast enhanced MRI in the assessment of therapeutic response to a disease-modifying anti-rheumatic drug: case study of a patient with rheumatoid arthritis-6- and 24-month follow up. Br J Rheumatol 1995;34:956-9.
18. Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A, et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852-8.
19. Cunnane G, Fitzgerald O, Beeton C, Cawston TE, Bresnihan B. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arthritis Rheum 2001;44: 2263-74.
20. Pritchard MH. Evidence for a hypothetical non-HLA susceptibility gene in rheumatoid arthritis. Br J Rheumatol 1994;33:475-9.
21. Woolley DE. Mast cells in the rheumatoid lesion: ringleaders or innocent bystanders? Ann Rheum Dis 1995;54:533-8.
22. Bell AL, Magill MK, McKane R, Irvine AE. Human blood and synovial fluid neutrophils cultured in vitro undergo programmed cell death which is promoted by the addition of synovial fluid. Ann Rheum Dis 1995;54:910-5.
23. Dummode DC, Glynn LE. The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol 1982;43: 373-83.
24. Pettipher ER, Henderson B, Moncada F, Higgs GA. Leucocyte infiltration and cartilage proteoglycan loss in immune arthritis in the rabbit. Br J Pharmacol 1988;95:169-76.
25. Sharif M, Salisbury C, Taylor DJ, Kirwan JR. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis. Arthritis Rheum 1998;41:1203-9.